Elektrofi

Elektrofi

Biotechnology, 451 D St Ste 707, Boston, Massachusetts, 02210, United States, 51-200 Employees

elektrofi.com

  • twitter
  • LinkedIn

phone no Phone Number: 18*********

Who is ELEKTROFI

Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to recei...

Read More

map
  • 451 D St Ste 707, Boston, Massachusetts, 02210, United States Headquarters: 451 D St Ste 707, Boston, Massachusetts, 02210, United States
  • 2016 Date Founded: 2016
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 54 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ELEKTROFI

Elektrofi Org Chart and Mapping

Employees

Zishu Gui

Senior Research Associate

Sakshi Singal

Senior Associate Scientist

Kara Lui

Process Engineer Co-Op

Angela Hui

Vice President, Operations

Lyndon Charles

Vice President, Program Management & Strategy

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Elektrofi

Answer: Elektrofi's headquarters are located at 451 D St Ste 707, Boston, Massachusetts, 02210, United States

Answer: Elektrofi's phone number is 18*********

Answer: Elektrofi's official website is https://elektrofi.com

Answer: Elektrofi's revenue is $1 Million to $5 Million

Answer: Elektrofi's SIC: 2834

Answer: Elektrofi's NAICS: 54

Answer: Elektrofi has 51-200 employees

Answer: Elektrofi is in Biotechnology

Answer: Elektrofi contact info: Phone number: 18********* Website: https://elektrofi.com

Answer: Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough ultra-high concentration microparticle technology platform resolves the limitations associated with intravenously biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are headquartered in Boston and innovate globally.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access